Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
暂无分享，去创建一个
J. Blay | E. Rasmussen | J. Soria | M. Gounder | P. Cassier | S. Chawla | F. Eskens | W. L. Gluck | A. Wagner | H. Henary | R. Frank | D. Siegel | V. D. de Weger | F. De vos | R. Frank | Jean-Yves Blay | Andrew J. Wagner | W. Larry Gluck | P. Cassier | R. Frank | Jean‐Yves Blay